The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Megalotect 100 U/mL solution for infusion



Biotest Pharma GmbHPA0592/008/001

Main Information

Trade NameMegalotect 100 U/mL solution for infusion
Active SubstancesHuman Cytomegalovirus Immunoglobulin
Dosage FormSolution for infusion
Licence HolderBiotest Pharma GmbH
Licence NumberPA0592/008/001

Group Information

ATC CodeJ06BB09 cytomegalovirus immunoglobulin

Status

License statusAuthorised
Licence Issued14/10/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back